PHARMACOLOGICAL EFFECT OF EZH2 INHIBITOR IN PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

被引：0
|
作者：
Iannotta, A. [1 ]
Ramaglia, M. [1 ]
Lombardi, A. [1 ]
D'Angelo, V. [1 ]
Caraglia, M. [1 ]
Affinita, M. C. [1 ]
Fusco, C. [1 ]
Di Martino, M. [1 ]
Di Pinto, D. [1 ]
Oreste, M. [1 ]
Indolfi, C. [1 ]
Indolfi, P. [1 ]
Casale, F. [1 ]
机构：
[1] Univ Naples 2, Naples, Italy
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-022
引用
收藏
页码：S258 / S259
页数：2
相关论文
共 50 条
  • [1] Leukaemia cutis in T-cell acute lymphoblastic leukaemia
    Ali, R
    CYTOPATHOLOGY, 2006, 17 (03) : 158 - 161
  • [2] Effect of rMnSOD on Survival Signaling in Pediatric High Risk T-Cell Acute Lymphoblastic Leukaemia
    Pica, A.
    Di Santi, A.
    D'angelo, V.
    Iannotta, A.
    Ramaglia, M.
    Di Martino, M.
    Pollio, M. L.
    Schiattarella, A.
    Borrelli, A.
    Mancini, A.
    Indolfi, P.
    Casale, F.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2015, 230 (05) : 1086 - 1093
  • [3] Is there a difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma?
    Uyttebroeck, Anne
    Vanhentenrijk, Vera
    Hagemeijer, Anne
    Boeckx, Nancy
    Renard, Marleen
    Wlodarska, Iwona
    Vandenberghe, Peter
    Depaepe, Pascale
    De Wolf-Peeters, Christiane
    LEUKEMIA & LYMPHOMA, 2007, 48 (09) : 1745 - 1754
  • [4] AntineoplasticsLineage switch from T-cell acute lymphoblastic leukaemia/lymphoma to acute myeloid leukaemia and relapse to T-cell acute lymphoblastic leukaemia/lymphoma: case report
    Reactions Weekly, 2019, 1762 (1) : 43 - 43
  • [5] EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches
    D'Angelo, V.
    Iannotta, A.
    Ramaglia, M.
    Lombardi, A.
    Zarone, M. R.
    Desiderio, V.
    Affinita, M. C.
    Pecoraro, G.
    Di Martino, M.
    Indolfi, P.
    Casale, F.
    Caraglia, M.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [6] EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches
    V. D’Angelo
    A. Iannotta
    M. Ramaglia
    A. Lombardi
    M. R. Zarone
    V. Desiderio
    M. C. Affinita
    G. Pecoraro
    M. Di Martino
    P. Indolfi
    F. Casale
    M. Caraglia
    Journal of Experimental & Clinical Cancer Research, 34
  • [7] Early T-cell precursor acute lymphoblastic leukaemia
    Haydu, J. Erika
    Ferrando, Adolfo A.
    CURRENT OPINION IN HEMATOLOGY, 2013, 20 (04) : 369 - 373
  • [8] T-cell therapy for paediatric acute lymphoblastic leukaemia
    Lokody, Isabel
    LANCET ONCOLOGY, 2014, 15 (12): : E536 - E536
  • [9] MiRNA expression in T-cell acute lymphoblastic leukaemia
    Kox, C.
    Breit, S.
    Costoldi, M.
    Kirschner-Schwabe, R.
    Ludwig, W. D.
    Hentze, M. W.
    Kulozik, A. E.
    Muckenthaler, M. U.
    KLINISCHE PADIATRIE, 2007, 219 (03): : 187 - 187
  • [10] EPIGENETIC REMODELLING ON INK4A-ARF (CDKN2A) TUMOR SUPPRESSOR LOCUS BY EZH2 IN PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Indolfi, P.
    Ramaglia, M.
    Iannotta, A.
    D'Angelo, V.
    Scianguetta, S.
    Fusco, C.
    Oreste, M.
    Martinelli, I.
    Fiano, P.
    Pecoraro, G.
    Indolfi, C.
    Casale, F.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 223 - 224
12345